Impact of the Location of CpG Methylation within the GSTP1 Gene on Its Specificity as a DNA Marker for Hepatocellular Carcinoma
Authors:
Open Access
- 20 April 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (4) , e35789
Abstract
Hypermethylation of the glutathione S-transferase π 1 (GSTP1) gene promoter region has been reported to be a potential biomarker to distinguish hepatocellular carcinoma (HCC) from other liver diseases. However, reports regarding how specific a marker it is have ranged from 100% to 0%. We hypothesized that, to a large extent, the variation of specificity depends on the location of the CpG sites analyzed. To test this hypothesis, we compared the methylation status of the GSTP1 promoter region of the DNA isolated from HCC, cirrhosis, hepatitis, and normal liver tissues by bisulfite–PCR sequencing. We found that the 5′ region of the position −48 nt from the transcription start site of the GSTP1 gene is selectively methylated in HCC, whereas the 3′ region is methylated in all liver tissues examined, including normal liver and the HCC tissue. Interestingly, when DNA derived from fetal liver and 11 nonhepatic normal tissue was also examined by bisulfite-PCR sequencing, we found that methylation of the 3′ region of the promoter appeared to be liver-specific. A methylation-specific PCR assay targeting the 5′ region of the promoter was developed and used to quantify the methylated GSTP1 gene in various diseased liver tissues including HCC. When we used an assay targeting the 3′ region, we found that the methylation of the 5′-end of the GSTP1 promoter was significantly more specific than that of the 3′-end (97.1% vs. 60%, pGSTP1 gene. This study clearly demonstrates the importance of the location of CpG site methylation for HCC specificity and how liver-specific DNA methylation should be considered when an epigenetic DNA marker is studied for detection of HCC.Keywords
This publication has 41 references indexed in Scilit:
- Methylation of the CpG Sites Only on the Sense Strand of the APC Gene Is Specific for Hepatocellular CarcinomaPLOS ONE, 2011
- Analysis of Promoter CpG Island Hypermethylation in Cancer: Location, Location, Location!Clinical Cancer Research, 2011
- The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targetsSeminars in Cancer Biology, 2011
- Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinomaMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2010
- DNA methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infectionExperimental and Molecular Pathology, 2010
- Hepatocellular Carcinoma Displays Distinct DNA Methylation Signatures with Potential as Clinical PredictorsPLOS ONE, 2010
- Molecular profiling to predict hepatocellular carcinoma outcomeExpert Review of Gastroenterology & Hepatology, 2009
- Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinomaHepatology, 2008
- Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinomaBritish Journal of Cancer, 2007
- The Hallmarks of CancerCell, 2000